302 related articles for article (PubMed ID: 30890887)
1. Pathogenic mechanisms of neurodegeneration based on the phenotypic expression of progressive forms of immune-mediated neurologic disease.
Levin MC; Lee S; Gardner LA; Shin Y; Douglas JN; Groover CJ
Degener Neurol Neuromuscul Dis; 2012; 2():175-187. PubMed ID: 30890887
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to heterogeneous nuclear ribonuclear protein A1 (hnRNPA1) cause altered 'ribostasis' and neurodegeneration; the legacy of HAM/TSP as a model of progressive multiple sclerosis.
Levin MC; Lee S; Gardner LA; Shin Y; Douglas JN; Salapa H
J Neuroimmunol; 2017 Mar; 304():56-62. PubMed ID: 27449854
[TBL] [Abstract][Full Text] [Related]
3. Molecular mimicry: cross-reactive antibodies from patients with immune-mediated neurologic disease inhibit neuronal firing.
Kalume F; Lee SM; Morcos Y; Callaway JC; Levin MC
J Neurosci Res; 2004 Jul; 77(1):82-9. PubMed ID: 15197740
[TBL] [Abstract][Full Text] [Related]
4. Autoimmunity due to molecular mimicry as a cause of neurological disease.
Levin MC; Lee SM; Kalume F; Morcos Y; Dohan FC; Hasty KA; Callaway JC; Zunt J; Desiderio D; Stuart JM
Nat Med; 2002 May; 8(5):509-13. PubMed ID: 11984596
[TBL] [Abstract][Full Text] [Related]
5. Neuroimmunology of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis.
Nozuma S; Jacobson S
Front Microbiol; 2019; 10():885. PubMed ID: 31105674
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies that recognize functional domains of hnRNPA1 implicate molecular mimicry in the pathogenesis of neurological disease.
Lee SM; Dunnavant FD; Jang H; Zunt J; Levin MC
Neurosci Lett; 2006 Jun; 401(1-2):188-93. PubMed ID: 16600502
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to the RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein A1 Colocalize to Stress Granules Resulting in Altered RNA and Protein Levels in a Model of Neurodegeneration in Multiple Sclerosis.
Douglas JN; Gardner LA; Salapa HE; Levin MC
J Clin Cell Immunol; 2016 Apr; 7(2):402. PubMed ID: 27375925
[TBL] [Abstract][Full Text] [Related]
8. HTLV-1 induced molecular mimicry in neurological disease.
Lee SM; Morcos Y; Jang H; Stuart JM; Levin MC
Curr Top Microbiol Immunol; 2005; 296():125-36. PubMed ID: 16323422
[TBL] [Abstract][Full Text] [Related]
9. Significantly increased antibody response to heterogeneous nuclear ribonucleoproteins in cerebrospinal fluid of multiple sclerosis patients but not in patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
Yukitake M; Sueoka E; Sueoka-Aragane N; Sato A; Ohashi H; Yakushiji Y; Saito M; Osame M; Izumo S; Kuroda Y
J Neurovirol; 2008 Apr; 14(2):130-5. PubMed ID: 18444084
[TBL] [Abstract][Full Text] [Related]
10. Antibody transfection into neurons as a tool to study disease pathogenesis.
Douglas JN; Gardner LA; Lee S; Shin Y; Groover CJ; Levin MC
J Vis Exp; 2012 Sep; (67):. PubMed ID: 23051967
[TBL] [Abstract][Full Text] [Related]
11. Neuronal molecular mimicry in immune-mediated neurologic disease.
Levin MC; Krichavsky M; Berk J; Foley S; Rosenfeld M; Dalmau J; Chang G; Posner JB; Jacobson S
Ann Neurol; 1998 Jul; 44(1):87-98. PubMed ID: 9667596
[TBL] [Abstract][Full Text] [Related]
12. An insight to HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) pathogenesis; evidence from high-throughput data integration and meta-analysis.
Mozhgani SH; Piran M; Zarei-Ghobadi M; Jafari M; Jazayeri SM; Mokhtari-Azad T; Teymoori-Rad M; Valizadeh N; Farajifard H; Mirzaie M; Khamseh A; Rafatpanah H; Rezaee SA; Norouzi M
Retrovirology; 2019 Dec; 16(1):46. PubMed ID: 31888669
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to the RNA binding protein heterogeneous nuclear ribonucleoprotein A1 contribute to neuronal cell loss in an animal model of multiple sclerosis.
Libner CD; Salapa HE; Hutchinson C; Lee S; Levin MC
J Comp Neurol; 2020 Jul; 528(10):1704-1724. PubMed ID: 31872424
[TBL] [Abstract][Full Text] [Related]
14. Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis.
Nozuma S; Kubota R; Jacobson S
J Neurovirol; 2020 Oct; 26(5):652-663. PubMed ID: 32705480
[TBL] [Abstract][Full Text] [Related]
15. HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP): a chronic progressive neurologic disease associated with immunologically mediated damage to the central nervous system.
Levin MC; Jacobson S
J Neurovirol; 1997 Apr; 3(2):126-40. PubMed ID: 9111175
[TBL] [Abstract][Full Text] [Related]
16. CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis.
Menezes SM; Decanine D; Brassat D; Khouri R; Schnitman SV; Kruschewsky R; López G; Alvarez C; Talledo M; Gotuzzo E; Vandamme AM; Galvão-Castro B; Liblau R; Weyenbergh JV
J Neuroinflammation; 2014 Jan; 11():18. PubMed ID: 24472094
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous nuclear ribonucleoprotein A1 in health and neurodegenerative disease: from structural insights to post-transcriptional regulatory roles.
Bekenstein U; Soreq H
Mol Cell Neurosci; 2013 Sep; 56():436-46. PubMed ID: 23247072
[TBL] [Abstract][Full Text] [Related]
18. Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence.
Primo JR; Brites C; Oliveira Mde F; Moreno-Carvalho O; Machado M; Bittencourt AL
Clin Infect Dis; 2005 Aug; 41(4):535-41. PubMed ID: 16028164
[TBL] [Abstract][Full Text] [Related]
19. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
20. An update on human T-cell leukemia virus type I (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) focusing on clinical and laboratory biomarkers.
Yamauchi J; Araya N; Yagishita N; Sato T; Yamano Y
Pharmacol Ther; 2021 Feb; 218():107669. PubMed ID: 32835825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]